From 2006 to 2015, insurance providers kept $9.1 billion more in taxpayer funds than they would have if their estimated cost forecasts for drug spending through Medicare had been more accurate. This eye-popping statistic comes courtesy of an in-depth report published Jan. 4 by the Wall-Street Journal.

The healthcare industry took the lead as the largest employer in the United States in 2018, with high rates of job growth continuing through the end of the year, according to recent data from the Bureau of Labor Statistics.

Verily, a subsidiary of Google parent company Alphabet, raised $1 billion in investment funding to support growth in strategic partnership investments, global business development opportunities and potential acquisitions, the company announced Jan. 3.

Denver-based Radiology Imaging Associates and San Antonio-based South Texas Radiology Group have partnered to create Covalent Radiology, a professional services company, and Covalent Healthcare Management, a full-service management services organization.

A Wall Street Journal investigation detailed how private health insurers have regularly overestimated the cost of covering prescription drug benefits for Medicare enrollees, allowing the insurers to keep $9.1 billion more from 2006 to 2015 than if their projections had been accurate.

Health insurers have been inflating cost estimates for providing prescription-drug benefits to more than 40 million Medicare beneficiaries, allowing them to cash in $9.1 billion in extra payments from 2006 to 2015, according to a report from The Wall Street Journal.

Radiology practices who hope to achieve success in CMS pay-for-performance programs should consider group participation rather than each radiologist participating as an individual, according to new research published in the Journal of the American College of Radiology.

The artificial intelligence (AI) in healthcare market is expected to reach $36.1 billion by 2025, according to a new report from the research firm MarketsandMarkets.